Paris, 16 July, 2021 – Jeantet advised IKONISYS, a company specializing in the early and accurate detection of cancers with a unique fully-automated solution for medical analysis labs, on its initial public offering on the market of Euronext Growth Paris, for a total of €4 million.
As part of the offering, 700,000 shares have been offered at an offering price of €5.75 per share. On this basis, the Company has a market capitalization of €55 million.
Settlement-delivery of the shares offered occurred on July 16, 2021. The shares will be admitted for continuous trading on the market of Euronext Growth Paris on July 19, 2021 (ISIN FR00140048X2 / ticker ALIKO).
The purpose of the offering and the admission of the Company’s shares to trading on Euronext Growth Paris is to enable the Group to finance the Company’s commercial strategy in the United States and in Europe and its R&D efforts.
Banque Delubac & Cie acted as Listing Sponsor, Lead Manager, Bookrunner and investment service provider.
– –
Jeantet (legal advisor of Ikonisys): Cyril Deniaud (Partner, Capital Markets), Benjamin Cohu (Associate, Capital Markets) and Fanny Alexanian (Associate, Capital Markets).